Basic Materials / Specialty ChemicalsIstanbul
$22.96
-0.20 (-0.86%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 15%
FCF escenarios
weak_data · normalized FCF $344.3M · quality 32.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
39/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$11.2B
P/E
135.1x
↑EV/EBITDA
20.7x
↑ROE
-10.3%
↓Gross Margin
18.9%
↓Debt/Equity
1.39
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+12.7%
FCF CAGR
+88.2%
FCF margin
2.6%
FCF / Net income
-0.97x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $13.42B · net income $-353.7M · FCF $344.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $13.42B | $13.42B | $17.34B | $15.35B | $9.37B |
| Net Income | $-353.7M | $-353.7M | $-1.37B | $877.2M | $418.8M |
| EBITDA | $725.6M | $725.6M | $1.16B | $2.35B | $1.14B |
| EPS | -0.73 | -0.73 | -2.81 | 1.80 | 2.53 |
| Gross Margin | 18.9% | 18.9% | 14.3% | 16.9% | 14.0% |
| Operating Margin | 11.5% | 11.5% | 10.0% | 11.3% | 10.0% |
| Net Margin | -2.6% | -2.6% | -7.9% | 5.7% | 4.5% |
| Balance Sheet | |||||
| Debt/Equity | 1.39 | 1.39 | 1.29 | 1.33 | 1.31 |
| Current Ratio | 1.16 | 1.16 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $344.3M | $344.3M | $-1.46B | $1.13B | $51.6M |
| Returns | |||||
| ROE | -10.3% | -10.3% | -39.6% | 22.4% | 16.7% |
| Valuation | |||||
| P/E | 135.06 | 135.06 | — | 17.07 | 10.26 |
| EV/EBITDA | 20.73 | 20.73 | 11.65 | 7.91 | 6.88 |
| P/B | 3.25 | 3.25 | 2.73 | 3.82 | 2.43 |
| Growth & Yield | |||||
| Revenue Growth | -22.6% | -22.6% | 12.9% | 63.9% | — |
| EPS Growth | 74.0% | 74.0% | -256.1% | -28.9% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+60.6%
Start / end P/E
n/dx → n/dx
EPS bridge
-2.81 → -0.73
Residual
+60.6%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.